{"transactions":[{"id":3565189,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":158576,"kind":"person","name":"During Matthew","position":1,"cik":"0001704631","reported_name":"During Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-03T16:42:57.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares will become exercisable immediately and the remaining shares shall vest monthly thereafter over subsequent three years subject to the Reporting Person's continued service through such date."}],"balance_after":75000,"derivative":{"exercise_price":1.76,"expiration_date":"2029-03-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-19-023196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704631/000120919119023196/doc4.xml","form_type":"4"}},{"id":3632446,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":158576,"kind":"person","name":"During Matthew","position":1,"cik":"0001704631","reported_name":"During Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-26T21:42:00.000Z","date":"2019-02-24","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":70000,"derivative":{"exercise_price":1.89,"expiration_date":"2029-02-23","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-19-013904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704631/000120919119013904/doc4.xml","form_type":"4"}},{"id":4092449,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":158576,"kind":"person","name":"During Matthew","position":1,"cik":"0001704631","reported_name":"During Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CSO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-23T16:39:16.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date."}],"balance_after":110000,"derivative":{"exercise_price":9.18,"expiration_date":"2028-01-18","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-18-004905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704631/000120919118004905/doc4.xml","form_type":"4"}},{"id":4326706,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":158576,"kind":"person","name":"During Matthew","position":1,"cik":"0001704631","reported_name":"During Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CSO"}}],"security":"Series A Preferred Stock","published_at":"2017-05-10T17:14:55.000Z","date":"2017-05-10","kind":"exercise","acquired":false,"shares":28245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28245},"source":{"system":"sec-edgar","filing":"0001209191-17-031374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704631/000120919117031374/doc4.xml","form_type":"4"}},{"id":4326705,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":158576,"kind":"person","name":"During Matthew","position":1,"cik":"0001704631","reported_name":"During Matthew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2017-05-10T17:14:55.000Z","date":"2017-05-10","kind":"exercise","acquired":true,"shares":28245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering, on a one-for-one basis and had no expiration date."}],"balance_after":4307314,"source":{"system":"sec-edgar","filing":"0001209191-17-031374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704631/000120919117031374/doc4.xml","form_type":"4"}}]}